| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Contemporary Update on Pathology Standards for Bladder Cancer: Transurethral Resection and Radical Cystectomy Specimens
|
Hansel, Donna E.
|
|
2013
|
63 |
2 |
p. 321-332
12 p.
|
artikel
|
| 2 |
Antibiotic Prophylaxis in Urology Departments, 2005–2010
|
Çek, Mete
|
|
2013
|
63 |
2 |
p. 386-394
9 p.
|
artikel
|
| 3 |
A Plea for Surgical Lymph Node Staging in Advanced Prostate Cancer
|
Liedberg, Fredrik
|
|
2013
|
63 |
2 |
p. 409-410
2 p.
|
artikel
|
| 4 |
A Randomized, Double-Blind, Dose-Finding, Multicenter, Phase 2 Study of Radium Chloride (Ra 223) in Patients with Bone Metastases and Castration-Resistant Prostate Cancer
|
Parker, Christopher C.
|
|
2013
|
63 |
2 |
p. 189-197
9 p.
|
artikel
|
| 5 |
Award pages
|
|
|
2013
|
63 |
2 |
p. e15-e19
nvt p.
|
artikel
|
| 6 |
Congress Calendar
|
|
|
2013
|
63 |
2 |
p. 413-418
6 p.
|
artikel
|
| 7 |
Conservative Management of Upper Tract Urothelial Carcinoma in France: A 2004–2011 National Practice Report
|
Colin, Pierre
|
|
2013
|
63 |
2 |
p. 405-406
2 p.
|
artikel
|
| 8 |
Contemporary Role of Systematic Prostate Biopsies: Indications, Techniques, and Implications for Patient Care
|
Ukimura, Osamu
|
|
2013
|
63 |
2 |
p. 214-230
17 p.
|
artikel
|
| 9 |
Contents
|
|
|
2013
|
63 |
2 |
p. vi-
1 p.
|
artikel
|
| 10 |
Cost Effectiveness of Treatment Options for Early Prostate Cancer: Can We Put the Puzzle Pieces Together?
|
Xie, Feng
|
|
2013
|
63 |
2 |
p. 411-412
2 p.
|
artikel
|
| 11 |
Could Interferon Still Play a Role in Metastatic Renal Cell Carcinoma? A Randomized Study of Two Schedules of Sorafenib Plus Interferon-Alpha 2a (RAPSODY)
|
Bracarda, Sergio
|
|
2013
|
63 |
2 |
p. 254-261
8 p.
|
artikel
|
| 12 |
Current Status and Future Directions of Robotic Single-Site Surgery: A Systematic Review
|
Autorino, Riccardo
|
|
2013
|
63 |
2 |
p. 266-280
15 p.
|
artikel
|
| 13 |
Editorial Board
|
|
|
2013
|
63 |
2 |
p. i-ii
nvt p.
|
artikel
|
| 14 |
Efficacy and Tolerability of Mirabegron, a β3-Adrenoceptor Agonist, in Patients with Overactive Bladder: Results from a Randomised European–Australian Phase 3 Trial
|
Khullar, Vik
|
|
2013
|
63 |
2 |
p. 283-295
13 p.
|
artikel
|
| 15 |
Epidemiology and Risk Factors of Urothelial Bladder Cancer
|
Burger, Maximilian
|
|
2013
|
63 |
2 |
p. 234-241
8 p.
|
artikel
|
| 16 |
Eraser Laser Enucleation of the Prostate: Technique and Results
|
Hruby, Stephan
|
|
2013
|
63 |
2 |
p. 341-346
6 p.
|
artikel
|
| 17 |
Exome Sequencing of Prostate Cancer Supports the Hypothesis of Independent Tumour Origins
|
Lindberg, Johan
|
|
2013
|
63 |
2 |
p. 347-353
7 p.
|
artikel
|
| 18 |
From Diagnostic Tool to Disease Monitoring: The Growing Role of Prostate Biopsies
|
Graefen, Markus
|
|
2013
|
63 |
2 |
p. 231-233
3 p.
|
artikel
|
| 19 |
From Genes to Metabolomics in Renal Cell Carcinoma Translational Research
|
Mulders, Peter F.A.
|
|
2013
|
63 |
2 |
p. 252-253
2 p.
|
artikel
|
| 20 |
Initial Prostate Biopsy: Development and Internal Validation of a Biopsy-specific Nomogram Based on the Prostate Cancer Antigen 3 Assay
|
Hansen, Jens
|
|
2013
|
63 |
2 |
p. 201-209
9 p.
|
artikel
|
| 21 |
Interferon-α in Combination with Sorafenib: RAPSODY or Requiem?
|
Bex, Axel
|
|
2013
|
63 |
2 |
p. 262-264
3 p.
|
artikel
|
| 22 |
Metabolism of Kidney Cancer: From the Lab to Clinical Practice
|
Sudarshan, Sunil
|
|
2013
|
63 |
2 |
p. 244-251
8 p.
|
artikel
|
| 23 |
Mirabegron as a New Class of Oral Drug for Overactive Bladder Syndrome: Many Positive Perspectives, Some Concerns
|
Novara, Giacomo
|
|
2013
|
63 |
2 |
p. 306-308
3 p.
|
artikel
|
| 24 |
New and Emerging Therapies for Bone Metastases in Genitourinary Cancers
|
Saylor, Philip J.
|
|
2013
|
63 |
2 |
p. 309-320
12 p.
|
artikel
|
| 25 |
Oncologic Outcomes and Survival in pT0 Tumors After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: Results from of a Large Multicenter International Collaborative Study
|
Rouprêt, Morgan
|
|
2013
|
63 |
2 |
p. 404-405
2 p.
|
artikel
|
| 26 |
Pathologic Nodal Staging Score for Bladder Cancer: A Decision Tool for Adjuvant Therapy After Radical Cystectomy
|
Shariat, Shahrokh F.
|
|
2013
|
63 |
2 |
p. 371-378
8 p.
|
artikel
|
| 27 |
Patients with Lynch Syndrome Mismatch Repair Gene Mutations Are at Higher Risk for Not Only Upper Tract Urothelial Cancer but Also Bladder Cancer
|
Skeldon, Sean C.
|
|
2013
|
63 |
2 |
p. 379-385
7 p.
|
artikel
|
| 28 |
Polyamine-modulated Factor-1 Methylation Predicts Bacillus Calmette-Guérin Response in Patients with High-grade Non–muscle-invasive Bladder Carcinoma
|
Alvarez-Múgica, Miguel
|
|
2013
|
63 |
2 |
p. 364-370
7 p.
|
artikel
|
| 29 |
Potential Role of Genetic Markers in the Management of Kidney Cancer
|
Junker, Kerstin
|
|
2013
|
63 |
2 |
p. 333-340
8 p.
|
artikel
|
| 30 |
Primary Prevention and Early Detection of Bladder Cancer: Two Main Goals for Urologists
|
Brausi, Maurizio A.
|
|
2013
|
63 |
2 |
p. 242-243
2 p.
|
artikel
|
| 31 |
Prostate Cancer Antigen 3 to Select Men for Prostate Biopsy: Stop, Go, or Proceed with Caution?
|
Abern, Michael R.
|
|
2013
|
63 |
2 |
p. 210-211
2 p.
|
artikel
|
| 32 |
Randomized Double-blind, Active-controlled Phase 3 Study to Assess 12-Month Safety and Efficacy of Mirabegron, a β3-Adrenoceptor Agonist, in Overactive Bladder
|
Chapple, Christopher R.
|
|
2013
|
63 |
2 |
p. 296-305
10 p.
|
artikel
|
| 33 |
Real-time Magnetic Resonance–guided High-intensity Focused Ultrasound Focal Therapy for Localised Prostate Cancer: Preliminary Experience
|
Napoli, Alessandro
|
|
2013
|
63 |
2 |
p. 395-398
4 p.
|
artikel
|
| 34 |
Re: A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-stage Renal Cell Carcinoma
|
Kluth, Luis A.
|
|
2013
|
63 |
2 |
p. 399-400
2 p.
|
artikel
|
| 35 |
Re: Characterization of the Early Proliferative Response of the Rodent Bladder to Subtotal Cystectomy: A Unique Model of Mammalian Organ Regeneration
|
Lin, Ching-Shwun
|
|
2013
|
63 |
2 |
p. 401-402
2 p.
|
artikel
|
| 36 |
Recurrent Urinary Tract Infections Caused by Multidrug-resistant Uropathogenic Escherichia coli: Implications for Diagnosis and Treatment
|
Liu, Shiwei
|
|
2013
|
63 |
2 |
p. 410-411
2 p.
|
artikel
|
| 37 |
Re: Does Salvage Radiation Therapy Change the Biology of Recurrent Prostate Cancer Based on PSA Doubling Times? Results from the SEARCH Database
|
Lange, Paul H.
|
|
2013
|
63 |
2 |
p. 402-403
2 p.
|
artikel
|
| 38 |
Re: Giacomo Novara, Vincenzo Ficarra, Simone Mocellin, et al. Systematic Review and Meta-analysis of Studies Reporting Oncologic Outcome After Robot-assisted Radical Prostatectomy. Eur Urol 2012;62:382–404
|
Picozzi, Stefano C.M.
|
|
2013
|
63 |
2 |
p. e27-e28
nvt p.
|
artikel
|
| 39 |
Re: Jean J.M.C.H. de la Rosette, Dedan Opondo, Francisco P.J. Daels, et al., on behalf of the CROES PCNL Study Group. Categorisation of Complications and Validation of the Clavien Score for Percutaneous Nephrolithotomy. Eur Urol 2012;62:246–55
|
Biyani, Chandra Shekhar
|
|
2013
|
63 |
2 |
p. e23-e24
nvt p.
|
artikel
|
| 40 |
Re: Multilocular Cystic Renal Cell Carcinoma with Focus on Clinical and Pathobiological Aspects
|
Montironi, Rodolfo
|
|
2013
|
63 |
2 |
p. 400-401
2 p.
|
artikel
|
| 41 |
Re: Observation of Patients with Vesicoureteral Reflux Off Antibiotic Prophylaxis: Physician Bias on Patient Selection and Risk Factors for Recurrent Febrile Urinary Tract Infection
|
Kaplan, George W.
|
|
2013
|
63 |
2 |
p. 403-
1 p.
|
artikel
|
| 42 |
Reply from Author re: Axel Bex. Interferon-α in Combination with Sorafenib: RAPSODY or Requiem? Eur Urol 2013;63:262–4
|
Bracarda, Sergio
|
|
2013
|
63 |
2 |
p. 264-265
2 p.
|
artikel
|
| 43 |
Reply from Authors re: Michael R. Abern, Stephen J. Freedland. Prostate Cancer Antigen 3 to Select Men for Prostate Biopsy: Stop, Go, or Proceed with Caution? Eur Urol 2013;63:210–1
|
Hansen, Jens
|
|
2013
|
63 |
2 |
p. 212-213
2 p.
|
artikel
|
| 44 |
Reply to Chandra Shekhar Biyani, Andy Myatt, Victor Palit, Neil Burgess and Adrian D. Joyce's Letter to the Editor re: Jean J.M.C.H. de la Rosette, Dedan Opondo, Francisco P.J. Daels, et al., on behalf of the CROES PCNL Study Group. Categorisation of Complications and Validation of the Clavien Score for Percutaneous Nephrolithotomy. Eur Urol 2012;62:246–55
|
de la Rosette, Jean J.M.C.H.
|
|
2013
|
63 |
2 |
p. e25-e26
nvt p.
|
artikel
|
| 45 |
Reply to Henk G. van der Poel, Tessa Buckle and Renato Valdes Olmos’ Letter to the Editor re: Steven Joniau, Laura Van den Bergh, Evelyne Lerut, et al. Mapping of Pelvic Lymph Node Metastases in Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.06.057
|
Joniau, Steven
|
|
2013
|
63 |
2 |
p. e21-e22
nvt p.
|
artikel
|
| 46 |
Reply to Stefano C.M. Picozzi, Cristian Ricci and Luca Carmignani's Letter to the Editor re: Giacomo Novara, Vincenzo Ficarra, Simone Mocellin, et al. Systematic Review and Meta-analysis of Studies Reporting Oncologic Outcome After Robot-assisted Radical Prostatectomy. Eur Urol 2012;62:382–404
|
Novara, Giacomo
|
|
2013
|
63 |
2 |
p. e29-e31
nvt p.
|
artikel
|
| 47 |
Re: Steven Joniau, Laura Van den Bergh, Evelyne Lerut, et al. Mapping of Pelvic Lymph Node Metastases in Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.06.057
|
van der Poel, Henk G.
|
|
2013
|
63 |
2 |
p. e20-
1 p.
|
artikel
|
| 48 |
Tackling the Bone with Alpha Emitters in Metastatic Castration-resistant Prostate Cancer Patients
|
Bellmunt, Joaquim
|
|
2013
|
63 |
2 |
p. 198-200
3 p.
|
artikel
|
| 49 |
The Infancy of Robotic Laparoendoscopic Single-Site Renal Surgery: Waiting for Needed Technological Improvements
|
Ficarra, Vincenzo
|
|
2013
|
63 |
2 |
p. 281-282
2 p.
|
artikel
|
| 50 |
Thromboembolic Events Following Surgery for Prostate Cancer
|
Van Hemelrijck, Mieke
|
|
2013
|
63 |
2 |
p. 354-363
10 p.
|
artikel
|
| 51 |
Trends in the Landscape of Artificial Urinary Sphincter Implantation in Men and Women in France Over the Past Decade
|
Phé, Véronique
|
|
2013
|
63 |
2 |
p. 407-408
2 p.
|
artikel
|
Tijdschrift beschrijving